miR-215 promotes malignant progression of gastric cancer by targeting RUNX1
Oncotarget2015Vol. 7(4), pp. 4817–4828
Citations Over TimeTop 10% of 2015 papers
Na Li, Qiyue Zhang, Jianling Zou, Zhongwu Li, Tiantian Tian, Bin Dong, Xiaojian Liu, Sai Ge, Yan Zhu, Jing Gao, Lin Shen
Abstract
miR-215 promotes malignant progression of GC by targeting RUNX1, and RUNX1 can partially reverse miR-215 effects.
Related Papers
- → Enzyme-Instructed Assembly and Disassembly Processes for Targeting Downregulation in Cancer Cells(2017)146 cited
- → Downregulation of p21/WAF1 Expression by Thymidylate Synthase(2001)17 cited
- → Viral Infection and Abnormal Brain Development: A DNA Microarray Study(2007)1 cited
- → Book Review: The Life of Our Lord, The Life and Ministry of Jesus, Jesus and His Ministry(1955)
- → Book Review: III. Ministry Studies: 21 Bridges to the 21st Century: The Future of Pastoral Ministry(1994)